Asenapine versus olanzapine for the treatment of nausea and vomiting in patients with cancer: A retrospective study
Abstract Aim Patients with cancer often experience nausea and vomiting (N/V), but may have difficulty using olanzapine (OLZ), a common antiemetic. Asenapine (ASE) is a multi‐acting receptor‐targeted antipsychotic like OLZ, although there is little evidence that ASE serves as an antiemetic. The aim o...
Saved in:
Main Authors: | Tomohiko Kimura (Author), Akifumi Kanai (Author), Hiroyuki Muraoka (Author), Yuichiro Takahashi (Author), Masatomo Ara (Author), Ken Inada (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Olanzapine for chemotherapy-induced nausea and vomiting: systematic review and meta-analysis
by: Chelkeba L, et al.
Published: (2017) -
Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients
by: Ghufran salah ahmed, et al.
Published: (2023) -
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
by: Akihiro Uchiike, et al.
Published: (2023) -
Olanzapine for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: a randomized controlled trial
by: Nanjin Chen, et al.
Published: (2024) -
Olanzapine enhances the effect of conventional drugs in chemotherapy induced nausea and vomiting: A randomized clinical trial
by: Atefe Khani, et al.
Published: (2022)